Searched for
CADILLA HEALTHCARE
DPIIT official Manmeet Nanda appointed new MD & CEO of Invest IndiaIn its meeting held on Monday, the board approved the appointment of Nanda, an IAS officer of the West Bengal Cadre of 2000 Batch, as the M...- Govt to go by expert advice on vaccination for childrenIndia has given emergency use approval to Zydus Cadilla's ZyCoV-D vaccine which can be administered on individuals above 12 years.
- India to procure 27-28 crore COVID-19 vaccine doses in October: SourcesMeanwhile, the government said Zydus Cadila's indigenously-developed needle-free COVID-19 vaccine ZyCoV-D will be introduced in the nationw...
- Zydus Cadila gets USFDA nod to market Mesalamine suppositoriesThis will be manufactured at the group's topical manufacturing facility at Ahmedabad.
- Hold Cadila Healthcare, target Rs 380: Emkay Global Financial ServicesHold Cadila Healthcare Ltd. at a price target of Rs 380.0 .
- Carlyle Group leads race for 15 per cent in Mankind PharmaceuticalsThe company, which is the maker of leading brands such as Manforce condoms, PregaNews and Unwanted 72, has presence in about 22 countries a...
- Fund review: HDFC Balanced FundOver the past year, the fund returned an annualized 15.05 per cent.
- Buy Cadilla with a target of Rs 1,880: Mitesh Thacker'Cadilla Ltd is a 'BUY' call with a target of Rs 1,880 and a stop loss of Rs 1,754'
- Indian firms invested $ 1.29 billion overseas in SeptemberAlok Industries, Simplex Infrastructures, Tata Petrodyne, Cadilla Healthcare, Piramal Enterprises, Mercator and Bharti Airtel were among th...
- Buy Cadilla Healthcare with a target of 904: Deepak MohoniCadilla Healthcare Ltd is a ‘BUY’ call with a target of Rs 904 and a stop loss of Rs 855.
- Abbott, Dabur, GSK eye Jagdale’s energy drinks businessA line-up of MNC and Indian bidders are in the fray to acquire home grown electrolyte energy drinks business of Jagdale Healthcare.
- TCS, HDFC named India's best managed companiesTCS and HDFC are followed by IT major Infosys, telecom giant Bharti airtel and PSU behemoth ONGC in the list of the top-five best managed c...
- Lupin is a buy: Vikas Khemani, Edelweiss Securities LtdPharma space is a very good space and there is a reasonably good amount of growth visibility.
- Buy Cadilla Healthcare for target of Rs 768: AptartBuy Cadilla Healthcare in the range of Rs 740-735 with stoploss of Rs 728 for target of Rs 768. Price and volume breakout seen in the stock.
- India unveils first indigenous vaccine against swine fluIndia on Thursday unveiled its first indigenous vaccine against the dreaded swine flu which claimed over 18,000 lives globally and more tha...
- What to watch out forRBI is expected to leave interest rates unchanged this time, as a premature tightening may hurt the economic recovery.
- Zydus Cadila surges on drug discovery pact with Eli LillyShares of Zydus Cadila got a booster shot after the pharmaceutical company signed a new drug discovery and development agreement with Eli L...
- Five pharma companies to face legal actionAlembic, Cadilla Healthcare, Wockhardt, Lupin and Medley Pharmaceuticals would face legal action for allegedly selling 39 specified pack si...
- No 'Sugar Free' for AmulHC restrains Gujarat Co-operative Milk Marketing Federation from using Cadila's trademark "Sugar Free".
- SAP plans to double headcount by 2010SAP India has said it plans to double its headcount to 7,000 and increase its customer base to 15,000.
Load More
